Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Restructuring Costs (2020)

Ekso Bionics Holdings (EKSO) has disclosed Restructuring Costs for 1 consecutive years, with $244000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Restructuring Costs changed N/A to $244000.0 in Q2 2020 year-over-year; TTM through Sep 2021 was $244000.0, a N/A change, with the full-year FY2020 number at $244000.0, changed N/A from a year prior.
  • Restructuring Costs was $244000.0 for Q2 2020 at Ekso Bionics Holdings.
  • In the past five years, Restructuring Costs ranged from a high of $244000.0 in Q2 2020 to a low of $244000.0 in Q2 2020.